Search Results for: melanoma

October 18, 2020October 18, 2020

Understanding the potential benefits of adaptive therapy for metastatic melanoma

Melanoma News

Publication date: Oct 16, 2020 Adaptive therapy is an evolution-based treatment approach that aims to maintain tumor volume by employing minimum effective drug doses or timed drug holidays. For successful ... Read more

October 17, 2020October 17, 2020

Acral Lentiginous Melanoma Often Presents As Advanced Disease in Minority Patients

Melanoma News

Publication date: Oct 16, 2020 Patients with acral lentiginous melanoma (ALM) who are Black, Hispanic, and Asian generally present with more advanced lesions that are more ulcerated and thicker compared ... Read more

October 17, 2020October 17, 2020

Blood test could help identify best treatment for melanoma

Melanoma News

Publication date: Oct 17, 2020 Oct. 16 (UPI) — Cancer patients with high levels of cancer cells in their blood may benefit from receiving more aggressive drug treatment for melanoma, ... Read more

October 17, 2020October 17, 2020

Castle Biosciences Presents Data on DecisionDx-Melanoma at the Virtual European Association of Dermato-Oncology (EADO) Congress

Melanoma News

Publication date: Oct 17, 2020 Prospective, multi-center study data support use of DecisionDx(R)-Melanoma in T1-T2 melanoma patients 65 years and older to identify those with a low probability of sentinel ... Read more

October 17, 2020October 17, 2020

Melanoma Patient Network Europe

Melanoma Media

Publication date: Oct 16, 2020 Concepts Keywords Dimension Healthcare systems Eastern Europe Diagnosis advanced melanoma Europe Regional groups melanoma Healthcare RTT Melanoma Cancer Melon Melanoma Molecular Biology Melanocytic nevus Network ... Read more

October 16, 2020October 16, 2020

A promising new tool in the fight against melanoma

Melanoma News

Publication date: Oct 16, 2020 The research found that patients with high levels of circulating tumour DNA (ctDNA) – an important indicator of cancer in the blood-could potentially benefit from ... Read more

October 16, 2020October 16, 2020

ctDNA may predict outcomes with first-line, but not second-line immunotherapy for melanoma

Melanoma News

Publication date: Oct 16, 2020 Baseline levels of circulating tumor DNA (ctDNA) predicted responses to first-line, but not second-line, immune checkpoint inhibition in patients with melanoma. Clinical Cancer Research, a ... Read more

October 16, 2020October 16, 2020

Pre-analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients.

Melanoma Literature

Publication date: May 01, 2020 The combination of liquid biomarkers from a single blood tube can provide more comprehensive information on tumor development and progression in cancer patients compared to ... Read more

October 16, 2020October 16, 2020

Melanoma brain metastases: review of histopathological features and immune-molecular aspects.

Melanoma Literature

Publication date: Jun 08, 2020 Patients with melanoma brain metastases (MBM) have a dismal prognosis, but the unprecedented advances in systemic therapy alone or in combination with local therapy have ... Read more

October 16, 2020October 16, 2020

Autocrine Signaling of NRP1 Ligand Galectin-1 Elicits Resistance to BRAF-Targeted Therapy in Melanoma Cells.

Melanoma Literature

Publication date: Aug 08, 2020 Melanoma cells addicted to mutated BRAF oncogene activity can be targeted by specific kinase inhibitors until they develop resistance to therapy. We observed that the ... Read more